Four drugs asparaginase Erwinia chrysanthemi, asparaginase Escherichia coli, calaspargase pegol, and pegaspargase, have been approved by the FDA to treat ALL, whereas pegaspargase was also feasible in higher-stage NHL (Figure 2). Here, ASPG is linked to non-Hodgkin lymphoma.